加味丹参饮联合西药治疗冠心病心绞痛心血瘀阻证68例疗效观察

唐梅森; 黄政德; 向忠军; 黄海波; 彭岭; 李杰

doi:10.13288/j.11-2166/r.2015.05.010

您当前的位置：

首页 >

文章列表页 >

加味丹参饮联合西药治疗冠心病心绞痛心血瘀阻证68例疗效观察

临床研究 | 更新时间：2021-11-17

- 加味丹参饮联合西药治疗冠心病心绞痛心血瘀阻证68例疗效观察
- Observation on Jiawei Danshen Yin Combined with Western Medicine in the Treatment of 68 Cases of Angina Pectoris with Heart Blood Stasis Syndrome
- 中医杂志 2015年56卷第5期页码：395-397
- 作者机构：
  
  1. 湖南中医药大学中医学院
  2. 湖南中医药大学附属宁乡医院
- 作者简介：
- 基金信息：
  
  国家自然科学基金（81001518）;中国博士后科学基金（2012M521526,2013T60771）;霍英东教育基金会高校青年教师基金（131042）;湖南省科技厅计划项目（2013RS4038）
- DOI：10.13288/j.11-2166/r.2015.05.010
  中图分类号： R541.4
- 纸质出版：2015
- 稿件说明：
移动端阅览
[1]唐梅森,黄政德,向忠军,黄海波,彭岭,李杰.加味丹参饮联合西药治疗冠心病心绞痛心血瘀阻证68例疗效观察[J].中医杂志,2015,56(05):395-397.

TANG Meisen, HUANG Zhengde, XIANG Zhongjun, et al. Observation on Jiawei Danshen Yin Combined with Western Medicine in the Treatment of 68 Cases of Angina Pectoris with Heart Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2015, 56(5): 395-397.
[1]唐梅森,黄政德,向忠军,黄海波,彭岭,李杰.加味丹参饮联合西药治疗冠心病心绞痛心血瘀阻证68例疗效观察[J].中医杂志,2015,56(05):395-397. DOI： 10.13288/j.11-2166/r.2015.05.010.

TANG Meisen, HUANG Zhengde, XIANG Zhongjun, et al. Observation on Jiawei Danshen Yin Combined with Western Medicine in the Treatment of 68 Cases of Angina Pectoris with Heart Blood Stasis Syndrome[J]. Journal of Traditional Chinese Medicine2015, 56(5): 395-397. DOI： 10.13288/j.11-2166/r.2015.05.010.

摘要

目的观察加味丹参饮联合西药治疗冠心病心绞痛心血瘀阻证的临床疗效。方法将128例患者随机分为治疗组68例和对照组60例

对照组口服阿司匹林肠溶片每次0.1 g

每日1次;单硝酸酯异山梨酯片每次10 mg

每日3次;培哚普利片每次4 mg

每日1次;琥珀酸美托洛尔缓释片每次47.5 mg

每日1次;阿托伐他汀钙片每次10 mg

每日1次。治疗组在对照组基础上给予加味丹参饮

每日1剂

水煎分早晚两次口服。两组均治疗15天后观察临床疗效及心电图疗效

并观察不良反应。结果治疗组临床疗效总有效率为90.8%明显优于对照组的62.1%（P<0.01）;治疗组心电图总有效率为82.5%明显优于对照组的69.2%（P<0.05）。结论加味丹参饮联合西药治疗冠心病心绞痛心血瘀阻证临床疗效及心电图疗效均优于单纯西药

且无明显不良反应。

Abstract

Objective To observe the clinical efficacy of Jiawei Danshen Yin（ JWDSY） in the treatment of angina pectoris with heart blood stasis syndrome. Methods Totally 128 cases were randomly divided into treatment group of 68 cases and control group of 60 cases. The control group was treated with aspirin enteric-coated tablets

0. 1 g daily; isosorbide mononitrate tablets

10 mg each time

3 times a day; perindopril tablets

4 mg daily; metoprolol succinate extended release tablets

47. 5 mg daily; atorvastatin calcium tablets

10 mg daily. On the basis of that

the treatment group was added with JWDSY

decocted by water

one dose daily. After 15 days of treatment

the clinical efficacy

electrocardiogram（ ECG） efficacy and adverse reactions were observed. Results The clinical total effective rate of the treatment group was 90. 8%

better than the 62. 1% of the control group（ P < 0. 01）. The ECG effective rate of the treatment group（ 82. 5%） was significantly superior to that of the control group（ 69. 2%

P <0. 05）. Conclusion JWDSY combined with western medicine had better effects than western medicine alone in the treatment of angina pectoris with heart blood stasis syndrome

with no obvious adverse reactions.

关键词

Keywords

references

查看原文

浏览量

520

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

养心通脉方对冠心病血瘀证模型大鼠心肌组织甲基化关键基因蛋白及PERK/ATF4/CHOP信号通路的影响

基于客观化多模态数据融合的冠心病血瘀证诊断模型的构建

冠心病PCI术后血瘀证患者甘油三酯葡萄糖乘积指数与主要心血管不良事件风险的相关性

冠心病西北燥证与血瘀证罹患差异及与主要不良心血管事件相关性分析

血府逐瘀胶囊对冠心病心绞痛患者西雅图心绞痛量表评分影响的多中心前瞻性队列研究